GILD chmp recommends gilead’s trodelvy® plus keytruda® in pd-(l)1-positive first-line metastatic triple-negative breast cancer
Story updates
10:27:58 AM UTC
SquawkNews
GILD CHMP Recommends Gilead’s Trodelvy® Plus Keytruda® in PD-(L)1-Positive First-Line Metastatic Triple-Negative Breast Cancer
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.